Becton, Dickinson and Company (NYSE: BDX)
Medical Instruments & Supplies · Franklin Lakes, NJ, United States · Founded 1897
- Market capitalization: $65.0 billion
- Annual revenue: $21.84 billion
- Net income: $1.68 billion
- Employees: 75,000
- Sector: Healthcare
- Headquarters: Franklin Lakes, United States
- Founded: 1897
Source: Statvoo company profile for Becton, Dickinson and Company. Browse all 500+ companies
Becton, Dickinson and Company (BD) is a global medical technology company that manufactures and sells medical devices, instrument systems, and reagents. The company is the world's largest manufacturer of syringes and needles, and a major player in diagnostics, medication management, and surgical instruments. BD's products are used in virtually every hospital and clinical laboratory on the planet.
BD generates revenue from the sale of consumable medical supplies, diagnostic instruments and test kits, and medication management systems. The high-volume, recurring nature of consumables like syringes and blood collection tubes creates predictable revenue streams.
Founded in 1897 by Maxwell Becton and Fairleigh Dickinson in New York, BD pioneered the mass production of hypodermic needles. The $24 billion acquisition of C.R. Bard in 2017 significantly expanded BD's portfolio into vascular access and urology. The spin-off of Embecta, its diabetes care business, in 2022 sharpened the company's focus.
| Market Capitalization | $65.0B |
| Annual Revenue | $21.84B |
| Net Income | $1.68B |
| Profit Margin | 8% |
| Revenue per Employee | $291200K |
| Stock Exchange | NYSE |
| Ticker Symbol | BDX |
Financial data is approximate and based on most recent annual filings.
BD manufactures roughly 45 billion medical devices per year—more than any other company on Earth. During the COVID-19 pandemic, BD's syringe production was critical to global vaccination efforts, producing billions of injection devices.
BD is the ultimate picks-and-shovels play in healthcare—unglamorous but indispensable. The Bard integration is largely complete, and the simplified portfolio should allow management to focus on margin improvement and innovation.
What is Becton, Dickinson and Company's revenue?
Becton, Dickinson and Company generates approximately $21.84 billion in annual revenue.
How many employees does Becton, Dickinson and Company have?
Becton, Dickinson and Company employs approximately 75,000 people worldwide.
What is Becton, Dickinson and Company's market cap?
Becton, Dickinson and Company (BDX) has a market capitalization of approximately $65.0 billion on the NYSE.
When was Becton, Dickinson and Company founded?
Becton, Dickinson and Company was founded in 1897 and is headquartered in Franklin Lakes, NJ, United States.
Who is the CEO of Becton, Dickinson and Company?
Tom Polen is the current CEO of Becton, Dickinson and Company.
What is Becton, Dickinson and Company's website?
Becton, Dickinson and Company's official website is bd.com.
| CEO | Tom Polen |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Founded | 1897 |
| HQ | Franklin Lakes, NJ |
| Country | United States |
| Website | bd.com |
See traffic, security, and technical data for Becton, Dickinson and Company's website:
📊 bd.com stats 📋 WHOIS 🌐 DNS 🔒 SSL